Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries.
Ljupcho EfremovSemaw Ferede AberaAhmed BedirDirk VordermarkDaniel MedenwaldPublished in: Journal of cancer research and clinical oncology (2021)
The inclusion of temozolomide chemotherapy has considerably improved median OS in the older age groups but had a lesser effect in the younger age group of cases. The analysis showed survival improvements for each treatment option over time.